79 related articles for article (PubMed ID: 8721048)
1. New approaches to identification of antigens of Mycobacterium tuberculosis.
Wallis RS
Infect Agents Dis; 1996 Mar; 5(2):119-25. PubMed ID: 8721048
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium-specific human CD8 T cell responses.
Klein MR; Fox A
Arch Immunol Ther Exp (Warsz); 2001; 49(5):379-89. PubMed ID: 11798136
[TBL] [Abstract][Full Text] [Related]
3. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance.
Mustafa AS
Tuberculosis (Edinb); 2005; 85(5-6):367-76. PubMed ID: 16253561
[TBL] [Abstract][Full Text] [Related]
4. CD8+ T lymphocytes against mycobacterium tuberculosis.
Klein MR; McAdam KP
Arch Immunol Ther Exp (Warsz); 1999; 47(5):313-20. PubMed ID: 10604237
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
Wozniak TM; Ryan AA; Triccas JA; Britton WJ
Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects.
Silver RF; Li Q; Boom WH; Ellner JJ
J Immunol; 1998 Mar; 160(5):2408-17. PubMed ID: 9498784
[TBL] [Abstract][Full Text] [Related]
8. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).
Romano M; Rindi L; Korf H; Bonanni D; Adnet PY; Jurion F; Garzelli C; Huygen K
Vaccine; 2008 Nov; 26(48):6053-63. PubMed ID: 18822333
[TBL] [Abstract][Full Text] [Related]
10. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
11. Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model.
Rubakova E; Petrovskaya S; Pichugin A; Khlebnikov V; McMurray D; Kondratieva E; Baturina I; Kondratieva T; Apt A
Tuberculosis (Edinb); 2007 Mar; 87(2):134-44. PubMed ID: 17011827
[TBL] [Abstract][Full Text] [Related]
12. Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy.
Lee JS; Song CH; Lim JH; Lee KS; Kim HJ; Park JK; Paik TH; Jung SS; Jo EK
Inflamm Res; 2003 Jun; 52(7):297-304. PubMed ID: 12861395
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.
Sable SB; Plikaytis BB; Shinnick TM
Vaccine; 2007 Feb; 25(9):1553-66. PubMed ID: 17166640
[TBL] [Abstract][Full Text] [Related]
14. Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients.
Lee JS; Song CH; Kim CH; Kong SJ; Shon MH; Suhr JW; Jung SS; Lim JH; Kim HJ; Park JK; Paik TH; Jo EK
Med Microbiol Immunol; 2003 May; 192(2):61-9. PubMed ID: 12736818
[TBL] [Abstract][Full Text] [Related]
15. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
[TBL] [Abstract][Full Text] [Related]
16. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
Höhn H; Kortsik C; Zehbe I; Hitzler WE; Kayser K; Freitag K; Neukirch C; Andersen P; Doherty TM; Maeurer M
Scand J Immunol; 2007 May; 65(5):467-78. PubMed ID: 17444958
[TBL] [Abstract][Full Text] [Related]
17. Th2-type immune response observed in healthy individuals to sonicate antigen prepared from the most prevalent Mycobacterium tuberculosis strain with single copy of IS6110.
Rajavelu P; Das SD
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):95-102. PubMed ID: 15985228
[TBL] [Abstract][Full Text] [Related]
18. ProPred analysis and experimental evaluation of promiscuous T-cell epitopes of three major secreted antigens of Mycobacterium tuberculosis.
Mustafa AS; Shaban FA
Tuberculosis (Edinb); 2006 Mar; 86(2):115-24. PubMed ID: 16039905
[TBL] [Abstract][Full Text] [Related]
19. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.
Briken V; Porcelli SA; Besra GS; Kremer L
Mol Microbiol; 2004 Jul; 53(2):391-403. PubMed ID: 15228522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
